The ODPRN has conducted multiple studies that have both informed and evaluated the impact of drug policies in Ontario, and more broadly across Canada. This research includes a wide breadth of work ranging from large drug class reviews to specific rapid response projects resulting from decision makers’ pressing initiatives.
The Ontario Trillium Drug Program (TDP) is a catastrophic drug coverage program available to all Ontario residents (with or without insurance) that helps to reduce out-of-pocket expenses for those who have high drug-costs.
This study examined changing patterns of utilization, government spending and characteristics of people accessing the Ontario TDP to help better understand the burden of rising drug costs and use of catastrophic drug coverage in Ontario. Individuals over the age of 65 were excluded because they have universal access to public drug coverage in Ontario.